[2-(1-hydroxybutan-2-yloxy)-2-methoxyethyl] 5-[2-[1-[3-[2-[3-[2-[2-[(4R)-5-[[(2R,3R)-3-hydroxybutan-2-yl]amino]-4-(1H-indol-3-ylmethyl)-2,5-dioxopentoxy]ethoxy]ethylamino]-3-oxopropoxy]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylethylamino]-5-oxopentanoate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: [2-(1-hydroxybutan-2-yloxy)-2-methoxyethyl] 5-[2-[1-[3-[2-[3-[2-[2-[(4R)-5-[[(2R,3R)-3-hydroxybutan-2-yl]amino]-4-(1H-indol-3-ylmethyl)-2,5-dioxopentoxy]ethoxy]ethylamino]-3-oxopropoxy]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylethylamino]-5-oxopentanoate
• 化学式: C₄₈H₇₄N₆O₁₆S
• 分子量: 1023.2
• InChiKey: WSZHNFULPFIYMH-JFKKUJNFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.2
• 重原子数：
  71
• 可旋转键数：
  40
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  325
• 氢给体数：
  7
• 氢受体数：
  17

文献信息

• Protein-Polymer-Drug Conjugates
  申请人：MERSANA THERAPEUTICS, INC.

  公开号：US20140134127A1

  公开（公告）日：2014-05-15

  A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -L D -D, the protein based recognition-molecule being connected to the polymeric carrier by L P . Each occurrence of D is independently a therapeutic agent having a molecular weight ≦5 kDa. L D and L P are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.

  本文提供了一种药物结合物。该结合物包括基于蛋白质的识别分子（PBRM）和多聚载体，该多聚载体被取代了一个或多个-LD-D，蛋白质基于识别分子通过LP连接到多聚载体上。D的每个出现都是分子量≦5 kDa的治疗剂。LD和LP是连接治疗剂和PBRM到多聚载体的连接剂。还披露了用于与PBRM结合形成聚合物-药物-PBRM结合物的聚合物支架，包括结合物的组合物，其制备方法以及使用结合物或其组合物治疗各种疾病的方法。
• US8821850B2
  申请人：——

  公开号：US8821850B2

  公开（公告）日：2014-09-02